114 related articles for article (PubMed ID: 27323406)
1. Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.
Matondo RB; Toussaint MJ; Govaert KM; van Vuuren LD; Nantasanti S; Nijkamp MW; Pandit SK; Tooten PC; Koster MH; Holleman K; Schot A; Gu G; Spee B; Roskams T; Rinkes IB; Schotanus B; Kranenburg O; de Bruin A
Oncotarget; 2016 Aug; 7(34):54662-54675. PubMed ID: 27323406
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
[TBL] [Abstract][Full Text] [Related]
3. RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.
McClendon AK; Dean JL; Ertel A; Fu Z; Rivadeneira DB; Reed CA; Bourgo RJ; Witkiewicz A; Addya S; Mayhew CN; Grimes HL; Fortina P; Knudsen ES
Gastroenterology; 2011 Oct; 141(4):1439-50. PubMed ID: 21704587
[TBL] [Abstract][Full Text] [Related]
4. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
Zhou Z; Flesken-Nikitin A; Nikitin AY
Cancer Res; 2007 Jun; 67(12):5683-90. PubMed ID: 17553900
[TBL] [Abstract][Full Text] [Related]
6. Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression.
Nantasanti S; Toussaint MJ; Youssef SA; Tooten PC; de Bruin A
PLoS One; 2016; 11(3):e0150064. PubMed ID: 26967735
[TBL] [Abstract][Full Text] [Related]
7. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.
Nittner D; Lambertz I; Clermont F; Mestdagh P; Köhler C; Nielsen SJ; Jochemsen A; Speleman F; Vandesompele J; Dyer MA; Schramm A; Schulte JH; Marine JC
Nat Cell Biol; 2012 Sep; 14(9):958-65. PubMed ID: 22864477
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
Martínez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; García-Escudero R; Paramio JM
Cancer Res; 2008 Feb; 68(3):683-92. PubMed ID: 18245467
[TBL] [Abstract][Full Text] [Related]
9. Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors.
Yamauchi Y; Kodama Y; Shiokawa M; Kakiuchi N; Marui S; Kuwada T; Sogabe Y; Tomono T; Mima A; Morita T; Matsumori T; Ueda T; Tsuda M; Nishikawa Y; Kuriyama K; Sakuma Y; Ota Y; Maruno T; Uza N; Masuda A; Tatsuoka H; Yabe D; Minamiguchi S; Masui T; Inagaki N; Uemoto S; Chiba T; Seno H
Cancer Res; 2020 Sep; 80(17):3620-3630. PubMed ID: 32591410
[TBL] [Abstract][Full Text] [Related]
10. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
Vooijs M; te Riele H; van der Valk M; Berns A
Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
[TBL] [Abstract][Full Text] [Related]
11. αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation.
Petrovic V; Malin D; Cryns VL
Breast Cancer Res Treat; 2013 Apr; 138(2):415-25. PubMed ID: 23471649
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes.
Sheahan S; Bellamy CO; Treanor L; Harrison DJ; Prost S
Oncogene; 2004 Feb; 23(8):1489-97. PubMed ID: 14647424
[TBL] [Abstract][Full Text] [Related]
13. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status.
Sheahan S; Bellamy CO; Harland SN; Harrison DJ; Prost S
BMC Cancer; 2008 Jul; 8():191. PubMed ID: 18611248
[TBL] [Abstract][Full Text] [Related]
15. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
16. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
17. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.
Akeno N; Miller AL; Ma X; Wikenheiser-Brokamp KA
Oncogene; 2015 Jan; 34(5):589-99. PubMed ID: 24469052
[TBL] [Abstract][Full Text] [Related]
18. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
19. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
Choi J; Curtis SJ; Roy DM; Flesken-Nikitin A; Nikitin AY
Am J Pathol; 2010 Nov; 177(5):2645-58. PubMed ID: 20864684
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
He F; Mo L; Zheng XY; Hu C; Lepor H; Lee EY; Sun TT; Wu XR
Cancer Res; 2009 Dec; 69(24):9413-21. PubMed ID: 19951992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
